Edmund K. Waller, MD, PhD, FACP

Edmund K. Waller, MD, PhD, FACP, is currently a professor of medicine, pathology, hematology, and medical oncology at Emory University School of Medicine; director of the Regenerative Engineering and Medicine Center at Emory University; medical director of the Center for Stem Cell Processing and Apheresis at Emory University Hospital; and interim associate director of clinical research at the Winship Cancer Institute of Emory University, Atlanta, GA. He received his medical degree from Cornell University in Ithaca, NY, and his doctorate from The Rockefeller University in New York City as part of the tri-institutional MD-PhD Program. He completed his internal medicine residency training, a medical oncology clinical fellowship, and an experimental pathology fellowship at Stanford University. After working briefly at Becton, Dickinson and Company studying hematopoiesis, he joined the faculty of Emory University.

Dr Waller’s research focuses on optimizing antitumor immunity in patients with cancer and limiting graft-versus-host disease (GVHD) in recipients of allogeneic stem cell transplants. His clinical expertise is in graft engineering, stem cell selection, and adoptive immunotherapy to treat patients with cancer. He has led numerous clinical trials in graft engineering and GVHD prophylaxis and treatment. R01 funding for his research lab supports studies that are developing novel approaches to limit GVHD by examining the interaction between T cells and dendritic cells, microbial metabolites, and signaling through the receptor for vasoactive intestinal polypeptide.

Dr Waller has authored more than 340 peer-reviewed articles and book chapters, as well as 9 patents. He is the recipient of numerous awards and honors, including being a semifinalist for the Entrepreneur Award sponsored by the Wallace H. Coulter Foundation, a recipient of the Clinical Scholar Award from the Leukemia & Lymphoma Society, a recipient of the Clinical Investigator Award from the Cancer Research Institute, and a recipient of the Clinical Scientist Award from the Doris Duke Charitable Foundation. Dr Waller reviews government grants as the chair of the Translational Immuno-Oncology Study Section of the National Institutes of Health. He is the founding editor of ImmunoMedicine and has served on the editorial boards of Blood, the Journal of Clinical Oncology, and Biology of Blood and Marrow Transplantation.